Mevalonic aciduria / Hyper-IgD syndrome

Definition

Biallelic pathogenic variants in the MVK gene reduce or abolish the activity of mevalonate kinase, the enzyme that catalyzes the first step of the cholesterol biosynthesis pathway; disease severity is inversely proportional to residual enzyme activity. The severe end of the spectrum presents as mevalonic aciduria (psychomotor delay, ataxia); the mild end presents as hyper-IgD syndrome (recurrent fever attacks, lymphadenopathy, arthritis).

Gene/region analyzed

MVK - Exon 1, MVK - Exon 2, MVK - Exon 3, MVK - Exon 4, MVK - Exon 5, MVK - Exon 6, MVK - Exon 7, MVK - Exon 8, MVK - Exon 9, MVK - Exon 10, MVK - Exon 11

Method

Sequence analysis

Accepted sample types

EDTA blood, AF, CVS

Inheritance

Hereditary, autosomal recessive.

Related Tests